Published in J Urol on January 16, 2009
Prognostic role of systemic inflammatory response in renal cell carcinoma: a systematic review and meta-analysis. J Cancer Res Clin Oncol (2010) 1.27
C-reactive protein as a biomarker for urological cancers. Nat Rev Urol (2011) 1.21
Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein. Br J Cancer (2010) 1.18
Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients. BMC Cancer (2012) 1.14
C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review. PLoS One (2015) 1.03
Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems. Br J Cancer (2011) 1.01
Prognostic impact of pretreatment C-reactive protein for patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors. Int J Clin Oncol (2012) 1.00
Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy. World J Surg Oncol (2013) 0.99
Development of a nomogram incorporating serum C-reactive protein level to predict overall survival of patients with advanced urothelial carcinoma and its evaluation by decision curve analysis. Br J Cancer (2012) 0.90
Preoperative serum C- reactive protein: a prognostic marker in patients with upper urinary tract urothelial carcinoma. BMC Cancer (2013) 0.87
Prognostic Role of C-Reactive Protein In Urological Cancers: A Meta-Analysis. Sci Rep (2015) 0.86
Association of serum amyloid A protein and peptide fragments with prognosis in renal cancer. Br J Cancer (2010) 0.84
Tumor miR-125b predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection. Cancer Sci (2014) 0.83
External validation of the modified Glasgow prognostic score for renal cancer. Indian J Urol (2014) 0.81
Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinoma. Cancer Immunol Immunother (2011) 0.81
Increased serum hepcidin-25 level and increased tumor expression of hepcidin mRNA are associated with metastasis of renal cell carcinoma. BMC Cancer (2009) 0.81
Sex and the clinical value of body mass index in patients with clear cell renal cell carcinoma. Br J Cancer (2013) 0.77
Early response of C-reactive protein as a predictor of survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors. Int J Clin Oncol (2017) 0.75
Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy. Eur Urol (2007) 2.15
Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy. Eur Urol (2007) 2.11
New three-dimensional head-mounted display system, TMDU-S-3D system, for minimally invasive surgery application: procedures for gasless single-port radical nephrectomy. Int J Urol (2012) 2.08
The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am J Hum Genet (2004) 1.91
Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder. Clin Cancer Res (2003) 1.90
High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy. J Urol (2013) 1.76
Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy. Eur Urol (2008) 1.71
Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study). Diabetes Care (2002) 1.70
Diffusion-weighted magnetic resonance imaging in the differentiation of angiomyolipoma with minimal fat from clear cell renal cell carcinoma. Int J Urol (2011) 1.68
Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma. Eur Urol (2008) 1.67
Prognostic impact of C-reactive protein for determining overall survival of patients with castration-resistant prostate cancer treated with docetaxel. Urology (2011) 1.63
Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry. Clin Cancer Res (2009) 1.61
Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells. Int J Cancer (2011) 1.58
Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer. Urology (2009) 1.53
Radiotherapy to bone metastases from renal cell carcinoma with or without zoledronate. BJU Int (2008) 1.52
Effect of diabetes mellitus on high-grade prostate cancer detection among Japanese obese patients with prostate-specific antigen less than 10 ng/mL. Urology (2012) 1.48
Oxidative stress causes heart failure with impaired mitochondrial respiration. J Biol Chem (2006) 1.48
Surgical practices for urological tumors: a nation-wide survey in Japan in 2005. Int J Urol (2009) 1.48
Muscle-invasive urothelial carcinoma of the bladder. Urology (2007) 1.46
Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy. BJU Int (2015) 1.46
Relationship between bone mineral density and androgen-deprivation therapy in Japanese prostate cancer patients. Urology (2010) 1.46
Androgen receptors in gonadotrophs in pituitary cultures from adult male monkeys and rats. Endocrinology (2003) 1.46
Do testosterone levels have prognostic significance in patients with metastatic prostate cancer treated with combined androgen blockade? Int J Urol (2014) 1.44
Tonotopic specialization of auditory coincidence detection in nucleus laminaris of the chick. J Neurosci (2005) 1.43
Young age as favorable prognostic factor for cancer-specific survival in localized renal cell carcinoma. Urology (2011) 1.43
Renal function after radical nephrectomy: development and validation of predictive models in Japanese patients. Int J Urol (2013) 1.42
Body mass index influences prostate cancer risk at biopsy in Japanese men. Int J Urol (2012) 1.42
Squamous cell carcinoma with sarcomatous feature (so-called carcinosarcoma) of stomach probably metastasized from esophageal tumor: a case report with quick-freezing and deep-etching method. Med Electron Microsc (2004) 1.42
Electron holography on dynamic motion of secondary electrons around sciatic nerve tissues. J Electron Microsc (Tokyo) (2007) 1.40
Feasibility of antegrade radical prostatectomy for clinically locally advanced prostate cancer: a comparative study with clinically localized disease. Int J Urol (2010) 1.38
Successful 2-year-long remission following repeated salvage surgery in a patient with chemotherapy-resistant metastatic nonseminomatous germ cell tumor. Int J Clin Oncol (2007) 1.38